Global Human Fibrinogen 麻豆原创 Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

Publication ID:

PB505253923

Publication Date:

May 13, 2024

Pages:

122

Publisher:

MRRPB5

Countries:

Global [1]

USD 5,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Human Fibrinogen is used as a medicine for blood disease. Human Fibrinogen is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer鈥檚 products are justly used in local region or countries.
The global Human Fibrinogen market is projected to reach US$ 2207 million by 2030 from an estimated US$ 929.6 million in 2024, at a CAGR of 15.5% during 2024 and 2030.
Global Human Fibrinogen key players include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, GREEN CROSS, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest consumption market, with a share about 60%, followed by Americas and Europe, total have a share over 30 percent. In terms of product, Human Fibrinogen Concentrate is the largest segment, with a share over 99%. And in terms of application, the largest application is Surgical Procedures.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Fibrinogen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Human Fibrinogen.
The Human Fibrinogen market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Fibrinogen market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Fibrinogen manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
麻豆原创 Segmentation
By Company
CSL Behring
LFB Group
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
GREEN CROSS
Shanghai XinXing Medical
Octapharma
Segment by Type
Human Fibrinogen Concentrate
Animal Fibrinogen Concentrate
Segment by Application
Congenital Fibrinogen Deficiency
Surgical Procedures
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Human Fibrinogen in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Human Fibrinogen manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Fibrinogen sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Study Coverage
1.1 Human Fibrinogen Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Human Fibrinogen 麻豆原创 Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Human Fibrinogen Concentrate
1.2.3 Animal Fibrinogen Concentrate
1.3 麻豆原创 by Application
1.3.1 Global Human Fibrinogen 麻豆原创 Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Congenital Fibrinogen Deficiency
1.3.3 Surgical Procedures
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Fibrinogen 麻豆原创 Size Estimates and Forecasts
2.1.1 Global Human Fibrinogen Revenue 2019-2030
2.1.2 Global Human Fibrinogen Sales 2019-2030
2.2 Human Fibrinogen 麻豆原创 Size by Region: 2023 Versus 2030
2.3 Human Fibrinogen Sales by Region (2019-2030)
2.3.1 Global Human Fibrinogen Sales by Region: 2019-2024
2.3.2 Global Human Fibrinogen Sales Forecast by Region (2025-2030)
2.3.3 Global Human Fibrinogen Sales 麻豆原创 Share by Region (2019-2030)
2.4 Human Fibrinogen 麻豆原创 Estimates and Projections by Region (2025-2030)
2.4.1 Global Human Fibrinogen Revenue by Region: 2019-2024
2.4.2 Global Human Fibrinogen Revenue Forecast by Region (2025-2030)
2.4.3 Global Human Fibrinogen Revenue 麻豆原创 Share by Region (2019-2030)
3 Global Human Fibrinogen by Manufacturers
3.1 Global Top Human Fibrinogen Manufacturers by Sales
3.1.1 Global Human Fibrinogen Sales by Manufacturer (2019-2024)
3.1.2 Global Human Fibrinogen Sales 麻豆原创 Share by Manufacturer (2019-2024)
3.2 Global Top Human Fibrinogen Manufacturers by Revenue
3.2.1 Global Human Fibrinogen Revenue by Manufacturer (2019-2024)
3.2.2 Global Human Fibrinogen Revenue Share by Manufacturer (2019-2024)
3.3 Global Human Fibrinogen Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Human Fibrinogen Manufacturers Covered: Ranking by Revenue
3.4.2 Global Human Fibrinogen 麻豆原创 Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Human Fibrinogen 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Human Fibrinogen Manufacturing Base Distribution, Product Type
3.5.1 Human Fibrinogen Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Human Fibrinogen Product Type
3.5.3 Date of International Manufacturers Enter into Human Fibrinogen 麻豆原创
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 CSL Behring
4.1.1 CSL Behring Company Information
4.1.2 CSL Behring Description, Business Overview
4.1.3 CSL Behring Human Fibrinogen Products Offered
4.1.4 CSL Behring Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)
4.1.5 CSL Behring Human Fibrinogen Sales by Product in 2023
4.1.6 CSL Behring Human Fibrinogen Sales by Application in 2023
4.1.7 CSL Behring Human Fibrinogen Sales by Geographic Area in 2023
4.1.8 CSL Behring Recent Developments
4.2 LFB Group
4.2.1 LFB Group Company Information
4.2.2 LFB Group Description, Business Overview
4.2.3 LFB Group Human Fibrinogen Products Offered
4.2.4 LFB Group Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)
4.2.5 LFB Group Human Fibrinogen Sales by Product in 2023
4.2.6 LFB Group Human Fibrinogen Sales by Application in 2023
4.2.7 LFB Group Human Fibrinogen Sales by Geographic Area in 2023
4.2.8 LFB Group Recent Developments
4.3 Shanghai RAAS Blood Products
4.3.1 Shanghai RAAS Blood Products Company Information
4.3.2 Shanghai RAAS Blood Products Description, Business Overview
4.3.3 Shanghai RAAS Blood Products Human Fibrinogen Products Offered
4.3.4 Shanghai RAAS Blood Products Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Shanghai RAAS Blood Products Human Fibrinogen Sales by Product in 2023
4.3.6 Shanghai RAAS Blood Products Human Fibrinogen Sales by Application in 2023
4.3.7 Shanghai RAAS Blood Products Human Fibrinogen Sales by Geographic Area in 2023
4.3.8 Shanghai RAAS Blood Products Recent Developments
4.4 Jiangxi Boya Bio-Pharmaceutical
4.4.1 Jiangxi Boya Bio-Pharmaceutical Company Information
4.4.2 Jiangxi Boya Bio-Pharmaceutical Description, Business Overview
4.4.3 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Products Offered
4.4.4 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)
4.4.5 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Sales by Product in 2023
4.4.6 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Sales by Application in 2023
4.4.7 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Sales by Geographic Area in 2023
4.4.8 Jiangxi Boya Bio-Pharmaceutical Recent Developments
4.5 Hualan Biological Engineering
4.5.1 Hualan Biological Engineering Company Information
4.5.2 Hualan Biological Engineering Description, Business Overview
4.5.3 Hualan Biological Engineering Human Fibrinogen Products Offered
4.5.4 Hualan Biological Engineering Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Hualan Biological Engineering Human Fibrinogen Sales by Product in 2023
4.5.6 Hualan Biological Engineering Human Fibrinogen Sales by Application in 2023
4.5.7 Hualan Biological Engineering Human Fibrinogen Sales by Geographic Area in 2023
4.5.8 Hualan Biological Engineering Recent Developments
4.6 Harbin Pacific Biopharmaceutical
4.6.1 Harbin Pacific Biopharmaceutical Company Information
4.6.2 Harbin Pacific Biopharmaceutical Description, Business Overview
4.6.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Products Offered
4.6.4 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales by Product in 2023
4.6.6 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales by Application in 2023
4.6.7 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales by Geographic Area in 2023
4.6.8 Harbin Pacific Biopharmaceutical Recent Development
4.7 GREEN CROSS
4.7.1 GREEN CROSS Company Information
4.7.2 GREEN CROSS Description, Business Overview
4.7.3 GREEN CROSS Human Fibrinogen Products Offered
4.7.4 GREEN CROSS Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)
4.7.5 GREEN CROSS Human Fibrinogen Sales by Product in 2023
4.7.6 GREEN CROSS Human Fibrinogen Sales by Application in 2023
4.7.7 GREEN CROSS Human Fibrinogen Sales by Geographic Area in 2023
4.7.8 GREEN CROSS Recent Development
4.8 Shanghai XinXing Medical
4.8.1 Shanghai XinXing Medical Company Information
4.8.2 Shanghai XinXing Medical Description, Business Overview
4.8.3 Shanghai XinXing Medical Human Fibrinogen Products Offered
4.8.4 Shanghai XinXing Medical Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)
4.8.5 Shanghai XinXing Medical Human Fibrinogen Sales by Product in 2023
4.8.6 Shanghai XinXing Medical Human Fibrinogen Sales by Application in 2023
4.8.7 Shanghai XinXing Medical Human Fibrinogen Sales by Geographic Area in 2023
4.8.8 Shanghai XinXing Medical Recent Development
4.9 Octapharma
4.9.1 Octapharma Company Information
4.9.2 Octapharma Description, Business Overview
4.9.3 Octapharma Human Fibrinogen Products Offered
4.9.4 Octapharma Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)
4.9.5 Octapharma Human Fibrinogen Sales by Product in 2023
4.9.6 Octapharma Human Fibrinogen Sales by Application in 2023
4.9.7 Octapharma Human Fibrinogen Sales by Geographic Area in 2023
4.9.8 Octapharma Recent Development
5 Breakdown Data by Type
5.1 Global Human Fibrinogen Sales by Type (2019-2030)
5.1.1 Global Human Fibrinogen Sales by Type (2019-2024)
5.1.2 Global Human Fibrinogen Sales Forecast by Type (2025-2030)
5.1.3 Global Human Fibrinogen Sales 麻豆原创 Share by Type (2019-2030)
5.2 Global Human Fibrinogen Revenue Forecast by Type (2019-2030)
5.2.1 Global Human Fibrinogen Revenue by Type (2019-2024)
5.2.2 Global Human Fibrinogen Revenue Forecast by Type (2025-2030)
5.2.3 Global Human Fibrinogen Revenue 麻豆原创 Share by Type (2019-2030)
5.3 Human Fibrinogen Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Human Fibrinogen Sales by Application (2019-2030)
6.1.1 Global Human Fibrinogen Sales by Application (2019-2024)
6.1.2 Global Human Fibrinogen Sales Forecast by Application (2025-2030)
6.1.3 Global Human Fibrinogen Sales 麻豆原创 Share by Application (2019-2030)
6.2 Global Human Fibrinogen Revenue Forecast by Application (2019-2030)
6.2.1 Global Human Fibrinogen Revenue by Application (2019-2024)
6.2.2 Global Human Fibrinogen Revenue Forecast by Application (2025-2030)
6.2.3 Global Human Fibrinogen Revenue 麻豆原创 Share by Application (2019-2030)
6.3 Human Fibrinogen Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Human Fibrinogen 麻豆原创 Size YoY Growth 2019-2030
7.2 North America Human Fibrinogen 麻豆原创 Facts & Figures by Country
7.2.1 North America Human Fibrinogen Sales by Country (2019-2030)
7.2.2 North America Human Fibrinogen Revenue by Country (2019-2030)
7.3 North America Human Fibrinogen Sales by Type (2019-2024)
7.4 North America Human Fibrinogen Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Human Fibrinogen 麻豆原创 Size YoY Growth 2019-2030
8.2 Asia-Pacific Human Fibrinogen 麻豆原创 Facts & Figures by Region
8.2.1 Asia-Pacific Human Fibrinogen Sales by Region (2019-2030)
8.2.2 Asia-Pacific Human Fibrinogen Revenue by Region (2019-2030)
8.3 Asia-Pacific Human Fibrinogen Sales by Type (2019-2024)
8.4 Asia-Pacific Human Fibrinogen Sales by Application (2019-2024)
9 Europe
9.1 Europe Human Fibrinogen 麻豆原创 Size YoY Growth 2019-2030
9.2 Europe Human Fibrinogen 麻豆原创 Facts & Figures by Country
9.2.1 Europe Human Fibrinogen Sales by Country (2019-2030)
9.2.2 Europe Human Fibrinogen Revenue by Country (2019-2030)
9.3 Europe Human Fibrinogen Sales by Type (2019-2024)
9.4 Europe Human Fibrinogen Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Human Fibrinogen 麻豆原创 Size YoY Growth 2019-2030
10.2 Latin America Human Fibrinogen 麻豆原创 Facts & Figures by Country
10.2.1 Latin America Human Fibrinogen Sales by Country (2019-2030)
10.2.2 Latin America Human Fibrinogen Revenue by Country (2019-2030)
10.3 Latin America Human Fibrinogen Sales by Type (2019-2024)
10.4 Latin America Human Fibrinogen Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Human Fibrinogen 麻豆原创 Size YoY Growth 2019-2030
11.2 Middle East and Africa Human Fibrinogen 麻豆原创 Facts & Figures by Country
11.2.1 Middle East and Africa Human Fibrinogen Sales by Country (2019-2030)
11.2.2 Middle East and Africa Human Fibrinogen Revenue by Country (2019-2030)
11.3 Middle East and Africa Human Fibrinogen Sales by Type (2019-2024)
11.4 Middle East and Africa Human Fibrinogen Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Human Fibrinogen Supply Chain Analysis
12.2 Human Fibrinogen Key Raw Materials and Upstream Suppliers
12.3 Human Fibrinogen Clients Analysis
12.4 Human Fibrinogen Sales Channel and Sales Model Analysis
12.4.1 Human Fibrinogen Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Human Fibrinogen Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Human Fibrinogen Distributors
13 麻豆原创 Dynamics
13.1 Human Fibrinogen Industry Trends
13.2 Human Fibrinogen 麻豆原创 Drivers
13.3 Human Fibrinogen 麻豆原创 Challenges
13.4 Human Fibrinogen 麻豆原创 Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Companies Mentioned:

CSL Behring
LFB Group
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
GREEN CROSS
Shanghai XinXing Medical
Octapharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.